Introduction
A cancer diagnosis involving a rare genetic mutation can create unique treatment challenges for patients and families. In some cancers, abnormal genetic changes called ROS1 or NTRK gene fusions help drive tumor growth and spread. Precision oncology medications like Augtyro were developed to specifically target these genetic alterations and provide more personalized treatment options.
Augtyro is a targeted cancer therapy approved for certain adults with ROS1-positive non-small cell lung cancer (NSCLC) and eligible adults and pediatric patients with NTRK fusion-positive solid tumors. These cancers are identified through molecular or genetic testing that detects the specific gene fusion driving tumor growth.
Unlike traditional chemotherapy, Augtyro is designed to block abnormal signaling proteins involved in cancer progression. By targeting ROS1 and NTRK proteins directly, the medication may help slow or stop cancer growth in eligible patients.
One important feature of the medication is its activity against certain cancers that have spread to the brain or central nervous system. This may offer an additional treatment option for some patients with advanced or metastatic disease.
Augtyro is taken orally at home, which may provide added convenience for some patients compared to infusion-based cancer treatments. However, specialty oral oncology medications can also create significant financial concerns related to insurance coverage, specialty pharmacy access, copay obligations, and ongoing monitoring requirements.
Prescription Hope works with patients who are searching for ways to make medications more affordable. Through patient assistance programs and medication advocacy support, Prescription Hope helps eligible individuals navigate the enrollment process for affordable medications.
Understanding how Augtyro works, the cancers it treats, potential side effects, and available medication access resources helps patients understand what to ask their doctors and how to make the right decision with their healthcare provider.
What Is the Augtyro Patient Assistance Program?
Patients looking for affordable medication most likely have looked into various ways to save money on their medication.
Unfortunately, medications like Augtyro can be too expensive for Americans to pay out of pocket, and therefore, some patients must choose between their medications and bills.
Pharmaceutical manufacturers have developed a solution to help keep Americans from having to make that choice. Patient Assistance Programs offer patients who struggle financially access to affordable medications. For instance, the Augtyro Patient Assistance Program provides affordable Augtyro to qualified patients.
Unfortunately, many patient assistance programs are difficult to apply for and maintain strict regulations on access to the brand-name medications they offer. Patients have reported feeling overwhelmed, confused, and stressed when applying for patient assistance programs.
Some patients give up on the process, looking for other ways to hopefully save some money.
Prescription Hope has a solution.
How Expert Advocates Help Make Augtyro More Affordable
Professional Application Management
Prescription Hope offers professional application management for those looking to access patient assistance programs. Once patients are approved, Prescription Hope continues to manage refill schedules, document updates, program monitoring, and yearly renewals.
With Prescription Hope, patients no longer need to stress about all of the complexities of applying for their desired patient assistance program. Instead of focusing on phone calls, coordinating with healthcare providers, putting application packets together, following up, and everything else that comes with applying, patients can focus on what really matters – treating their condition and their loved ones.
Augtyro Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Predictable Monthly Pricing
Our service rate is a predictable, low $70.00 per month, per medication. We do not add extra charges or fees, and do not use complex pricing systems.
We advocate for our patients throughout the process, and then continue to advocate for them as long as they are patients with us.
Ongoing Advocacy and Refill Support
We don’t just fill out forms and submit documents when accessing your medication cost assistance. We coordinate with manufacturers, connect with your healthcare providers when needed, and manage your refill schedule, document updates, yearly renewals, and more.
Augtyro Patient Assistance Eligibility
If you’re curious about your Augtyro eligibility, it’s important to understand how patient assistance programs qualify people. Whether you’re looking for oncology assistance or other targeted therapy medication support, patient assistance programs work similarly. However, they each have their own requirements.
That being said, every program maintains qualification criteria in several general categories. Some of those categories include:
Income: Each patient assistance program maintains its own unique income threshold.
Insurance: Every program has its own insurance status requirements.
Prescription: All programs require applicants to have a valid prescription for the brand-name medication they’re applying for.
U.S. Resident: Every applicant must be a legal U.S. resident to qualify.
Simple Enrollment With Expert Support
Starting Your Journey
Looking to enroll in Augtyro assistance programs?
The enrollment process for the Augtyro patient assistance program through Prescription Hope takes only 6 steps:
- Submit Information: Be sure to complete our online enrollment form.
- Advocate Contact: Within 1-2 business days, our team will contact those who submit their enrollment form.
- Document Collection: Once a patient is prequalified, our team will collect all needed documentation.
- Provider Coordination: Team members will also collect healthcare provider signatures needed for application purposes.
- Program Submission: We’ll get your application in order and submit it to the manufacturer. We’ll continue to follow up on your behalf.
- Medication Delivery: Once approved, patients’ medication typically ships within 2 weeks directly to their door or doctor’s office.
All medications are shipped by the manufacturer. Prescription Hope does not handle medications at any time.
Medication Delivery and Ongoing Support
After your shipment arrives, we continue to handle your refill scheduling, document updates, yearly renewals, and more. Our team of dedicated patient advocates continues to monitor your account and handle any issues that might arise.
Understanding Augtyro
How Augtyro Works
Augtyro works by targeting abnormal ROS1 and NTRK proteins that help certain cancers grow and spread. These abnormal proteins are produced by genetic alterations known as gene fusions, which can continuously signal cancer cells to multiply.
The medication is classified as a tyrosine kinase inhibitor (TKI). By blocking the activity of ROS1 and NTRK signaling pathways, Augtyro may help slow or stop tumor progression in eligible patients whose cancers carry these genetic mutations.
Because ROS1 and NTRK gene fusions are only present in certain cancers, molecular or genetic testing is required before treatment begins. This testing helps healthcare providers identify patients who may benefit from Augtyro therapy.
Augtyro has also demonstrated activity in certain cancers involving central nervous system metastases, including cancers that have spread to the brain. The medication is administered orally as capsules and is generally managed through oncology specialists and specialty pharmacies.
What Conditions Does Augtyro Treat?
Augtyro is FDA-approved for:
- Adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC)
- Adults and pediatric patients 12 years of age and older with solid tumors that have an NTRK gene fusion and:
- cannot be surgically removed,
- have spread to other parts of the body, and
- have no satisfactory alternative treatments or have progressed following treatment
ROS1-positive and NTRK fusion-positive cancers occur when abnormal genetic changes drive tumor growth. These gene fusions may appear in different types of solid tumors, including lung cancer and other advanced cancers.
Because Augtyro targets specific genetic mutations rather than a single cancer type alone, treatment eligibility depends on molecular testing results and provider evaluation.
Healthcare providers consider factors such as prior treatment history, cancer progression, overall health, and genetic test findings when determining whether Augtyro is an appropriate treatment option.
Benefits of Treatment
For eligible patients with ROS1-positive or NTRK fusion-positive cancers, Augtyro may provide important treatment benefits as part of a precision oncology approach.
Potential benefits of Augtyro treatment may include:
- Targeted treatment for cancers driven by ROS1 or NTRK gene fusions
- Delayed cancer progression in eligible patients
- Activity against certain cancers involving brain metastases
- Oral administration at home
- An additional treatment option for some patients previously treated with other targeted therapies
- Durable response rates demonstrated in clinical studies
Clinical trials showed objective response rates in many patients with ROS1-positive NSCLC and NTRK fusion-positive tumors receiving Augtyro treatment.
Treatment outcomes vary depending on cancer type, extent of disease, prior therapies, and individual patient response. Ongoing monitoring with imaging studies and laboratory testing is typically required throughout treatment.
Important Safety Information and Side Effects
Like all cancer therapies, Augtyro may cause side effects and carries important safety considerations. Patients should discuss the risks and benefits of treatment with their oncology provider before starting therapy.
One important safety concern involves central nervous system effects. Patients may experience dizziness, coordination problems, cognitive changes, mood changes, or balance difficulties during treatment. These symptoms may affect daily activities, including driving or operating machinery.
Common side effects associated with Augtyro may include:
- Dizziness
- Fatigue
- Constipation
- Shortness of breath
- Tingling or numbness
- Muscle weakness
- Problems with coordination or balance
- Changes in taste
- Nausea
- Diarrhea
Additional serious safety considerations may include:
- Liver problems and elevated liver enzymes
- Muscle pain or elevated muscle enzyme levels
- Lung inflammation (interstitial lung disease or pneumonitis)
- QT interval prolongation and heart rhythm abnormalities
- Vision problems
- Bone fractures and skeletal growth abnormalities, particularly in pediatric patients
Regular monitoring during treatment may include liver function testing, neurological evaluations, muscle enzyme testing, imaging studies, and heart rhythm monitoring.
Augtyro may also increase sensitivity to sunlight. Patients are generally advised to avoid excessive sun exposure and use sun protection during treatment.
The medication can cause fetal harm during pregnancy. Patients should discuss pregnancy prevention and reproductive health considerations with their healthcare provider before beginning therapy.
Strong CYP3A inhibitors and inducers may affect Augtyro levels in the body, potentially requiring dose adjustments or medication changes. Patients should inform their healthcare provider about all medications, vitamins, and supplements they are taking before starting treatment.
Augtyro does not currently carry an FDA boxed warning.
Access to Multiple Medications
Need more than one medication?
Plenty of people who take Augtyro also need assistance for multiple medications to help treat symptoms, underlying conditions, and other medical conditions that need addressing.
Prescription Hope can help.
If you qualify for several brand-name medications, we can help. And our service rate doesn’t get more complicated, either.
For $70.00 per med, per month, we can help you with as many meds as you qualify for. That means if you qualify for the Augtyro Patient Assistance Program for your targeted cancer therapy support, and then qualify for other medications to help with things like nausea or muscle pain, we can help you with access to those brand-name medications.
Why Choose Prescription Hope for Augtyro Assistance
Experienced Advocacy Support
Our Florida-based staff deeply cares about your peace of mind and well-being. We love helping patients across America get access to their brand-name medications at affordable rates, and we’re eager to be your advocate during the patient assistance program process.
Ongoing Medication Management
We don’t just help you apply. We take care of things like refill scheduling, document updates, and yearly renewals. Let us take care of it so you can focus on loved ones and your treatment.
Transparent Monthly Pricing
Our service rate of $70.00 per month, per medication is predictable and easy to remember. Plus, our service rate includes your medication costs, which means no added medication costs on top of our service.
Nationwide Medication Access Support
For 20 years, Prescription Hope has cultivated a network that spans America. We work with hundreds of brand-name medications, making your medication access easier.
If you’re looking for affordable Augtyro assistance, then fill out our enrollment form today!
